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Abstract 22 
Objective: To identify early features of Fuchs’s endothelial dystrophy (FED) in carriers of the 23 
rs613872(G) transcription factor 4 gene (TCF4) aged 20-21 years.  24 
Design: Prospective cohort study 25 
Participants: People aged 20-21 years previously enrolled in the Western Australia Pregnancy 26 
(Raine) Cohort.  27 
Methods: Specular microscopy was performed using a non-contact specular microscopy (EM-28 
3000, Tomey, Nagoya, Japan). Individual genotype data were extracted from the genome-wide 29 
Illumina 660 Quad Array. Analysis of the association between the rs613872 risk allele in TCF4 30 
and specular microscopy measurements was conducted. 31 
Main Outcome Measures: Association between the rs613872 risk allele and corneal endothelial 32 
cell density as well as the coefficient of variation in cell shape.  33 
Results: Genotype and specular microscopy data were available for a total of 445 participants 34 
(46% female). The median cell density was 2851 and 2850 cells/mm2 in the right and left eyes, 35 
respectively. No significant differences between inter-eye variability in endothelial cell density 36 
were seen (right eye:left eye correlation = 0.64); however, a significant difference in variability 37 
of endothelial cell density between males and females was observed (male OD:2839±124 38 
cells/mm2 OS:2845±124 cells/mm2 vs female OD:2838±134 cells/mm2 OS:2842±132 cells/mm2; 39 
OD: p=0.0013, OS:p=0.0016). Eleven individuals were homozygous for the rs613872 risk allele. 40 
We found no association between rs613872 genotype and cell density or coefficient variation. 41 
3 
One of the eleven homozygous GG individuals was found to have a gutta in one sample field on 42 
specular microscopy while two of 297 TT individuals also had a gutta each in one sample field. 43 
Conclusions: We were unable to detect an association between TCF4 rs613872 genotype and the 44 
variation in corneal endothelial cell density or variation in cell morphology in a healthy young 45 
adult population.  46 
Financial Disclosure(s): The authors have no proprietary or commercial interest in any 47 
materials discussed in this article.  48 
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Fuch’s Endothelial Dystrophy (FED) is a leading indication for corneal transplants in individuals  49 
living in developed countries.(1) FED is a slowly  progressive, bilateral but asymmetric posterior 50 
corneal dystrophy clinically evident in the fifth and sixth decades of life(2,3) and later causes 51 
endothelial decompensation resulting in visual impairment.(4) The first sign of FED is the 52 
presence of guttae on Descemet’s membrane.(5)  The relationship between corneal endothelial 53 
cell count and the variability of cell size (polymegathism) with FED is inconsistent in the 54 
literature. (6, 7) FED is a complex heterogeneous disease affecting approximately 38% of first-55 
degree relatives of cases.(11)  However, previous work suggests that there is little difference in 56 
corneal endothelial cell count between first-degree relatives of individuals with FED.(8)  57 
Approximately 70% of Fuch’s original cohort was female and more recently Krachmer found 58 
that women were 2.5 times more likely than men to be affected. (9, 10, 11) Early onset disease has 59 
been associated with mutations in the COL8A2 gene located on chromosome 1p, presumably 60 
reflecting that the α2 subunit of collagen 8 is a component of Descemet’s layer.(12)  61 
Genome-wide association studies (GWAS) is a relatively new means of investigation and has 62 
been successful in identifying single nucleotide polymorphisms (SNPs) associated with macular 63 
degeneration, pseudoexfoliation, myopia and glaucoma (amongst others). 64 
GWAS holds great promise, particularly in the case of common complex diseases, because no 65 
prior information about underlying molecular mechanisms is required. In contrast to a candidate 66 
gene study, where typically only one particular gene locus is interrogated, in a GWAS several 67 
hundred thousand SNPs dispersed across the genome are simultaneously investigated for 68 
association with a disease. Mutations identified in KCNJ13 on chromosome 2q, SLC4A11 on 69 
chromosome 20p, and ZEB1 on chromosome 10p have also been associated with rare forms of 70 
FED.(13, 14, 15, 16)  Linkage of FED to chromosome 5q, 9p, 13p and 18q has been described.(16, 17, 18, 71 
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19)  Recently, a genome-wide association study (GWAS) identified a SNP in the transcription 72 
factor 4 gene (TCF4) (which encodes E2-2, a member of the E protein family) as being strongly 73 
associated with FED. (20)  Individuals with two copies of the high-risk allele were almost 30 times 74 
more likely to develop FED.(20)  A further study of 170 late onset FED cases and 180 age-75 
matched controls of Northern European descent interrogated 9 SNPs spanning the TCF4 locus 76 
and identified the rs61872 G risk allele as being significantly associated with late onset FED 77 
(p=4.28 x 10 -15, OR = 4.2)(21)  In this study we sought to specifically investigate the role of the 78 
TCF4 gene in the normal variation in corneal endothelium in a population-based cohort of 20- to 79 
21-year-old adults. 80 
 81 
Methods: 82 
The Western Australian Pregnancy Cohort (Raine) Study was established in Perth in 1989 when 83 
an unselected cohort of 2900 pregnant women was recruited at 16-18 weeks’ gestation from 84 
King Edward Memorial Hospital and surrounding practices. It is one of the largest ongoing 85 
prospective cohorts of pregnancy, childhood, adolescence, and young adulthood.(22)  The primary 86 
purpose of the Raine cohort was to investigate how events during pregnancy and at the time of 87 
birth subsequently influence health. Participants in the Raine study are currently being recruited 88 
and assessed as part of their 20- to 21-year-old follow-up, which includes each participant having 89 
specular microscopy measurements as part of a broad ophthalmic phenotyping. This is the first 90 
time that a comprehensive ophthalmic examination has been included as part of the Raine study 91 
follow up. A total of 522 individuals took part in a pilot study for the Raine Eye Health Study 92 
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(REHS). The REHS will compare ophthalmic diseases, traits and biometry with previously 93 
assembled GWAS and environmental data of the cohort. 94 
The REHS was conducted in accordance with the tenets of the Declaration of Helsinki, and the 95 
protocol was approved by the institutional review board at the University of Western Australia. 96 
Informed consent was obtained from all participants at the initiation of the examination session.  97 
Of the 522 individuals, 77 participants did not have genetic data available. A subset of 445 98 
individuals was selected for analysis based on the following criteria: singleton birth and no 99 
siblings in the study, Caucasian ethnicity, DNA sample, no congenital abnormalities and 100 
available phenotype and genotype data.    101 
Ophthalmic measurements were obtained from a maximum of 873 eyes (17 eyes did not have 102 
adequate images) of 445 participants examined with non-contact specular microscopy (EM-103 
3000, Tomey, Nagoya, Japan). For each eye, fifteen serial photographs of central corneal 104 
endothelium were recorded by using the auto alignment and auto shots functions of the 105 
instrument. The best quality image is automatically selected and analyzed by the pre-installed 106 
software of the instrument (Cell and Layer Analyser; Tomey). The following parameters were 107 
automatically determined using the fixed frame counting method in an area set to 100 µm2; the 108 
number of analyzed cells, cell density (CD), average cell size, standard deviation (SD), 109 
coefficient variation (CV), minimum and maximum values for cell area. No cell border 110 
correction was made. Central corneal thickness (CCT) was measured with the Tomey Specular 111 
Microscopy along with the corneal endothelial cell counts. Grading was not conducted at the 112 
time of testing and poor quality scans were later excluded and not repeated. 113 
 114 
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Study individual genotype data for rs613872 were extracted from the genome-wide Illumina 660 115 
Quad Array. Briefly, the genotyping was performed on the Illumina BeadArray Reader at the 116 
Centre for Applied Genomics (Toronto, Ontario, Canada) using 250 nanograms of DNA. Both 117 
the left and right eye measurements were analyzed separately. Cross-sectional analyses of the 118 
eye measures were performed using multivariate linear regression adjusting for gender and 119 
rs613872 genotype coded as AA, AC or CC (i.e. co-dominant genetic model).  The platform we 120 
used coded for the other strand of DNA, the SNP that was genotyped as A/C on our GWAS is 121 
presented that way in the text and tables of this manuscript but not the abstract, where we have 122 
transliterated to the HapMap database which used the other strand with T/G alleles. We have 123 
100% concordance between our genotyped and imputed data for this SNP.  124 
Age was investigated for association with each outcome but was non-significant over this small 125 
age range and was excluded from analysis. CD was approximately normally distributed, but CV 126 
was right skewed so a log transformation was performed prior to analysis. All analyses were 127 
performed using the statistical graphics software R version 2.7.1.(23)  A post-hoc power 128 
calculation was carried out in the Quanto software package(24)  to investigate whether this study 129 
had adequate power to detect a genetic association. In this study we had more than 80% power to 130 
detect an β≥57 cells/mm2 for CD and β≥0.05 for log(CV) under a log-additive genetic model for 131 
the SNP rs613872 at the ∝=0.05 level.  132 
 133 
Results: 134 
Of the 445 participants who were included in the analysis, 205 (46%) were female and 240 135 
(54%) male. The average age of the participants was 20.14 years (SD = 0.29).  136 
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The median CD and coefficient variations were determined for right and left eyes (Table 1). 137 
Regardless of the gender, the median CD was 2851 and 2850 cells/mm2 in the right and left eyes, 138 
respectively. There was no significant difference in CD between the left and right eye 139 
(correlation = 0.64). There was no significant difference in variability in endothelial cell size 140 
between the left and the right eye (correlation = 0.43); however, a difference was observed 141 
between males and females with respect to variability in endothelial cell density, which appeared 142 
to be due to a difference in standard deviation rather than average size.    143 
 144 
Table 1 Median (interquartile range) of cell density and coefficient of variation in pilot study, 145 
including the differences seen between males and females.  146 
(Table 1 here) 147 
 148 
The minor allele frequency of rs613872 was 0.18 (Number in each genotype category is: 149 
AA=297, AC=137, CC=11). The SNP was in Hardy-Weinberg equilibrium (P=0.42). and had 150 
100% call rate Association analysis between the CD and rs613872 genotype in the left and right 151 
eye is shown in Table 2. Association analysis between the cell size variability and rs613872 152 
genotype in the left and right eye is displayed in Table 3. 153 
 154 
Table 2  155 
Table 2 presents the effect size and statistical significance of each risk genotype of rs613872 in 156 
comparison to the major homozygote (AA) for the genetic association analysis of both cell 157 
density and coefficient of variation.  158 
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In the HapMap A is annotated by the other strand T and C as G.  159 
 160 
 161 
(Table 2 here) 162 
 163 
No significant association was detected between either CD or cell size variability and rs613872 164 
genotype in this sample of 445 individuals. An analysis of the other endothelial cell counts 165 
available, including number of cells, average and SD of cell size, minimum and maximum cell 166 
size, demonstrated no obvious associations with the rs613872 genotype, except for in the 167 
minimum cell size variable, which indicated an increased minimum cell size with the more 168 
copies of the risk (C) allele.  169 
Association analysis using an additive genetic model was conducted for each SNP within an 800 170 
kilobase of chromosome 18 that spans the TCF4 gene and beyond from the imputed data. Figure 171 
1 indicates that SNPs across the TCF4 region were not associated with CD and cell size 172 
variability in this sample after a Bonferonni adjustment for the multiple tests conducted (P<7x10-173 
5).  174 
 175 
(Figure 1 here) 176 
 177 
Figure 1  178 
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Association results of endothelial cell density and size variability for single nucleotide 179 
polymorphisms (SNPs) at the Chromosome 18q21 TCF4 locus. SNPs are plotted according to 180 
chromosomal location (x-axis) and the level of association for each SNP is displayed as the –181 
log10 p value, with stronger associations being displayed higher on the y-axis. The colour scheme 182 
indicates linkage disequilibrium between rs613872 and other SNPs in the region, where warmer 183 
colours represent stronger correlation between the relative SNPs. The corresponding position of 184 
the TCF4 gene is depicted in the ideogram at the bottom of each plot. Panels display the right 185 
and left eyes separately. 186 
 187 
One of the homozygous carriers of the risk allele showed a single endothelial gutta in the 188 
measurement zone of the left eye. The participants had specular microscopy that was not graded 189 
at the time of examination and follow up of abnormal results was not possible. No other carrier 190 
had any abnormality detected.  Two of the non-carriers had a single endothelial gutta each in 191 
their sample field. 192 
 193 
As Fuchs endothelial dystrophy is associated with corneal edema we also compared CCT in the 194 
cohort. CCT measurements were available on 436 right eyes (236 male, 200 female) and 437 left 195 
eyes (238 male, 199 female). Mean (SD) for CTT measurement total set genders combined:  196 
Right: 534.7µm (34.6µm), Left: 527.9µm (34.7µm); genders separated: Male Right: 533.6µm 197 
(35.8µm), Female Right: 535.9µm (33.3µm), Male Left: 526.6µm (36.5µm), Female Left: 198 
529.5µm (32.4µm). There was no significant difference between male and females; however, 199 
there was an unexplained difference between right and left eyes (p=0.004).  200 
11 
Discussion:  201 
Identification of the TCF4 locus has enabled detection of those at high risk for developing FED. 202 
Through following people who harbour FED causing TCF4 mutations closely we hope to 203 
recognize early signs of the disease and to identify other potential risk factors that exacerbate 204 
progression in those at increased genetic risk. 205 
This study reveals that guttae, one of the early signs of FED, were not common among those 206 
young adults carrying the high risk alleles for the disease (one in 22 eyes). The youngest affected 207 
individual with a COL8A2 mutation in other genetic studies of FED was pre-symptomatic in his 208 
third decade with 1–2 mm of grouped central corneal guttae (12) . In addition there was no 209 
difference in corneal endothelial CD or polymegathism when compared to wild type controls. 210 
Follow-up studies of at-risk individuals in cohorts of young adults such as this will be of value in 211 
understanding the onset of visual impairment from FED. The finding in this study of an 212 
increased variability of cell size (greater distribution) in females compared with males may 213 
explain the higher prevalence of FED dystrophy in women. Further genetic investigation of 214 
endothelial cell counts with GWAS may identify a sex-limited gene associated with this and 215 
FED. The G allele of rs613872 was not previously found to be more prevalent in females with 216 
FED.(21)  Although the G allele of rs613872 was associated with increased risk for FED, it was 217 
not associated with severity of disease.(21) Limitations of this study include the relatively small 218 
number of individuals involved. It is hoped that we will be able to expand the study to a full 219 
1,500 individuals with available genetic data in the coming years. Only one specular microscopy 220 
reading was taken and this was not graded at the time of participant assessment. Moreover, 221 
further corneal examination to confirm other pathology and other signs of FED was not 222 
conducted.  223 
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In conclusion identification of risk alleles in the TCF4 gene by Baratz and colleagues20 allows 224 
pre-symptomatic detection of individuals at higher risk of FED.  225 
 We did not identify any significant abnormality in endothelial cell counts in homozygous 226 
carriers aged 20-21 years and guttae were not common in high-risk individuals of this age (one 227 
of 11 homozygous carriers compared with two of 297 non-carriers).  228 
 229 
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Table 1 Median (interquartile range) of cell density and coefficient of variation in pilot study, 
including the differences seen between males and females 
Variable Total (n=445) Males (n=240) Females (n=205) P* 
Cell Density (cells/mm2)    
Right  2851 (2692, 3006) 2846 (2688, 2998) 2864 (2715,3008) 0.502 
Left 2850 (2706, 2974) 2843 (2707, 2962) 2858 (2704, 2985) 0.722 
Coefficient Variation   
Right 37.00 (33.00, 42.00) 36.00 (32.00, 40.00) 37.50 (34.00, 44.00) <0.001 
Left 36.00 (33.00, 41.00) 35.00 (32.00, 40.00) 38.00 (34.00, 42.00) <0.001 
Average Cell 
size (µm2) 
    
Right 350.5 (333.0,371.2) 351.0 (333.2,372.0) 349.0 (332.2,368.0) 0.473 
Left 351.0 (336.0,369.0) 351.5 (337.0,369.0) 350.0 (334.5,369.5) 0.709 
SD Cell size 
(µm2) 
    
Right 127.0 (114.0,148.2) 124.0 (113.0,142.8) 132.0 (116.2,156.0) 0.001 
Left 127.0 (114.0,146.0) 124.0 (112.8,140.2) 134.0 (115.5,150.5) 0.002 
*T-test was used to test for a difference in means of normally distributed outcomes (cell density) and wilcoxon rank 
sum test was used to test for a difference in medians for skewed outcomes (coefficient of variation, average and SD) 
 
 
Table 2: Results of genetic association analysis between cell density, coefficient of variation and 
rs613872 genotype 
 
 Left Eye Right Eye 
Cell Density 
 Effect (SE) P-value Effect (SE) P-value 
rs613872 heterozygote (AC) -21.34 (24.77) 0.389 8.58 (25.87) 0.740 
rs613872 risk homozygote 
(CC) 
-61.06 (72.52) 0.400 -116.78 (76.07) 0.125 
Loge(coefficient of variation) 
 Effect (SE) P-value Effect (SE) P-value 
rs613872 heterozygote (AC) 0.018 (0.019) 0.329 0.025 (0.019) 0.193 
rs613872 risk homozygote 
(CC) 
-0.028 (0.054) 0.603 -0.049 (0.059) 0.405 
 
 
 

